James Bochnowski from Delphi will join Sequent’s board of directors as part of the deal.
Tom Wilder, the company’s president and CEO, said it plans to use the funds to support clinical, commercial and technological development programs for its product lines.
Delphi also took part in the $32m Series C round for minimally invasive hip restoration specialists Pivot Medical last November.
The firm, which has focused on early-stage medical and biotechnology investments for the past two decades, has more than $1.1bn in committed capital under management.
Copyright © 2012 AltAssets